US has recorded over 570 Mpox cases so far in 2024

The horror of Mpox has returned to scare the US asmore than 570 cases of Mpox have been detected in the US so far in 2024 — almost double the number seen by this time last year.

At the peak of the Mpox outbreak in early August 2022, the US witnessed an average of about 470 new cases in a week.

According to the latest information, mpox is still a problem and vaccination is still necessary for those who are susceptible to infection.

JYNNEOS, the most popular Mpox vaccine in the United States, is administered in two doses spaced a month apart. Two weeks following the second dosage, a person is fully immunised, and booster shots are not currently advised.

One can check the eligibility for the vaccine and where to get the shots on the Centers for Disease Control and Prevention (CDC) website.

Various local health departments, such as those of New York City and San Francisco, also have their own vaccine site finders.

Dr Jenni McQuiston, deputy director of the CDC's High-Consequence Pathogens and Pathology division, told ABC News, "Most of the cases that are being reported are either unvaccinated or under-vaccinated, meaning they either never received a vaccine, or they only got one dose."

It may be noted here, Mpox formerly known as monkeypox, is caused by a relative of the now-eradicated variola virus, which causes smallpox.

The Mpox virus'two broad types are,clade I and clade II. Clade I is more likely than clade II to cause fatal disease. However,clade I has not been detected in the UStodate, but it is possible that travellers could carry the virus to the country from other places, such as the Democratic Republic of the Congo, the CDC cautioned in December 2023. The JYNNEOS vaccine guards against both clades.

Generally speaking, Mpox viruses can produce flu-like symptoms such as fever, sore muscles, exhaustion, and enlarged lymph nodes. However, not every case had these symptoms in 2022 when the outbreak peaked. The characteristic pox rashes of the illness usually begin as discoloured patches that scab over and peel off, followed by raised bumps, blisters, and big pus-filled pimples.

Depending on the situation, these rashes may start in the mouth and on the cheeks before moving to the other areas of the body, or they may start in the genitalia and anus.

People with severely weakened immune systems, including those with HIV; children younger than 1 year; people with a history of eczema; and people who are pregnant face a higher risk of severe disease from Mpox. The disease most often spreads through close contact with an infected person, especially through contact with their rashes.

More than 30,000 cases of Mpox have been reported in the US since the outbreak began in May 2022; the majority of those cases occurred in 2022. Infection rates have decreased by the beginning of 2023; between January 1 and March 23, 2023, 298 cases were reported in the US.

This year, there were over 110 cases in New York City, 64 in California, and 50 in Florida.

The Virginia Department of Health recently issued a notice about the dozen Mpox cases it's seen so far in 2024, in part because it saw 12 in all of 2023.

(With inputs from agencies)